Loading…
Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review
Objectives To extract the microbiological and immunological evidence underpinning the association between periodontitis and inflammatory bowel disease (IBD). Methods Relevant articles were sorted through a systematic search on PubMed, Embase, Scopus and Web of Science up to October 2020. Available e...
Saved in:
Published in: | Oral diseases 2022-05, Vol.28 (4), p.1029-1041 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
To extract the microbiological and immunological evidence underpinning the association between periodontitis and inflammatory bowel disease (IBD).
Methods
Relevant articles were sorted through a systematic search on PubMed, Embase, Scopus and Web of Science up to October 2020. Available evidence was grouped in three different clusters: (a) studies that examined oral microbial alterations in IBD patients; (b) studies that investigated intestinal dysbiosis in patients with periodontitis; and (c) evidence for a shared immunological pattern between the two conditions.
Results
A total of 15 studies involving 1,171 patients were included. Oral microbiome, either subgingival or salivary, was consistently altered in patients with IBD compared to healthy subjects (a) Additionally, gut dysbiotic microbiota of IBD patients was colonized by pathobionts from oral origin, either via haematogenous or enteric route. Suffering from periodontitis is associated with lower alpha diversity in the gut microbiome (b) Lastly, both IBD and periodontitis are characterized by similar expression patterns of inflammatory cytokines at the gingival and gut levels that are exacerbated when both diseases are present (c).
Conclusions
Periodontitis and IBD share common dysbiotic and immunological traits. Well‐designed preclinical models and longitudinal cohort studies are required to better explore the causal pathways between the two conditions (PROSPERO CRD42020194379). |
---|---|
ISSN: | 1354-523X 1601-0825 |
DOI: | 10.1111/odi.13843 |